GENUONE SCIENCES

◼︎ Held its first corporate event with partners at the 63 Convention Center on the 15th, with 100 major partners across 50 departments in attendance ◼︎ Created a space for communication by sharing major industry news conducted by outside lecturers and networking with partner companies ◼︎ GENUONE announces investment and management plans for 2024, with plans to increase productivity by investing KRW 23.8 billion in large-capacity facilities   ▲ On the 15th November, GENUONE hosted the Genuone Customer Day, inviting partnering companies to mark its third anniversary (Image provided by GENUONE Sciences)   (2023-11-16)On November 16th, GENUONE Sciences (CEO Lee Sam-soo, hereinafter GENUONE), Korea's leading synthetic drug CDMO (Contract Development Manufacturing Organization), announced that the company had held a Genuone Customer Day to mark its third anniversary. On the 15th November, GENUONE invited some 100 major partners from across 50 departments to the 63 Convention Center in Yeouido, Seoul. The event was the first of its kind since the launch of GENUONE and was held to express gratitude to partner companies that have continued to cooperate with GENUONE and to share views on the current status of the industry. On this day, GENUONE invited external lecturers to share insights into the current status of the industry. Experts in each field gave lectures on unregistered patents and prospects of pharmaceutical pricing as a result of changes in the external environment with closing opportunities offered for networking. At the event, GENUONE also announced plans to expand production capacity through facility investment worth about KRW 23.8 billion in 2024. With such significant investment, GENUONE seeks to increase production volume and quality in order to offer improved services and encourage win-win collaborations. GENUONE already made an investment of KRW 12.5 billion last year to upgrade its production capacity. The additional investment of KRW 23.8 billion was largely driven by IMM PE, the shareholder company, to actively innovate GENUONE’s management and improve efficiency. Based on this investment, the company will make further efforts to increase production efficiency. “This first partner’s event was prepared for our partners, who have been with us for a long time. We wanted to create a place for communication so that we can grow together, share our futures, and build more than just a business relationship,” said Lee Sam-soo, CEO of GENUONE. He added, “We will step up our efforts to strengthen quality and expand production in order to take off as a global CDMO company. We will also continue to cooperate with our partners, and strengthen our competitiveness in the future”.